Relevant data show that, as one of the more common diseases in the clinic, drug-resistant tuberculosis has a greater impact on the health of patients. In general, the main feature of drug-resistant tuberculosis is that it has strong drug resistance to treatment drugs, which makes the treatment difficult and is not conducive to the reasonable maintenance of health of patients. Researchers said that as one of the most important public health problems worldwide at this stage, drug-resistant tuberculosis is mainly caused by the improper use of anti-tuberculosis drugs in the medical industry. According to incomplete statistics, the number of patients with drug-resistant tuberculosis in our country is about 140,000, which has caused a serious impact and threat to the health of the people. At the same time, as there is no therapeutic drug with a new mechanism of action and chemical structure, it is relatively difficult to control the disease. This article analyzes and discusses the development of the comprehensive treatment of drug-resistant tuberculosis, with the aim of effectively promoting the improvement and optimization of the treatment effect of the disease. |